"Pharmacologic Substance"^^ . . "PALA DisodiumSYNCI" . "CI-882CNNCI" . "Sparfosate Sodium"^^ . "Sparfosate SodiumPTNCI" . "PALA_Disodium"^^ . "FDA"^^ . "C6H8NO8P.2Na"^^ . "SPARFOSATE SODIUMPTFDA5R33Q73DYD" . . "Sparfosate Sodium"^^ . . "Amino Acid, Peptide, or Protein"^^ . "N-Phosphonacetyl-L-aspartate DisodiumSNNCI" . "66569-27-5"^^ . . "5R33Q73DYD"^^ . . "C2353"^^ . "C1518775"^^ . "The disodium salt form of N-phosphonacetyl-L-aspartate (PALA), a pyrimidine antimetabolite with antineoplastic activity. PALA inhibits pyrimidine biosynthesis and increases the extent to which fluorouracil is incorporated into RNA. (NCI04)NCI" . "L-Aspartic Acid, N-(phosphonoacetyl)-, Disodium SaltSNNCI" .